Literature DB >> 24475800

Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation.

Min Jung Park1, Young Kon Kim, Sanghyeok Lim, Hyunchul Rhim, Won Jae Lee.   

Abstract

PURPOSE: To assess the benefit of adding diffusion-weighted (DW) imaging to gadoxetic acid-enhanced magnetic resonance (MR) imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma.
MATERIALS AND METHODS: The institutional review board approved this retrospective study and waived the requirement for informed consent. The study included 52 patients (36 men, 16 women; mean age, 63.4 years) with surgically confirmed hilar cholangiocarcinoma who underwent gadoxetic acid-enhanced MR imaging and DW imaging at 3.0 T between August 2010 and December 2011. Two observers independently reviewed two image sets--a gadoxetic acid set, including images from MR cholangiopancreatography, and a combined gadoxetic acid set and DW imaging set--to evaluate the tumor involvement of each biliary confluence and vascular and liver invasion by using receiver operating characteristic (ROC) curve analysis.
RESULTS: For each observer, area under the ROC curve (Az) values for tumor involvement of the biliary confluence were 0.965 and 0.957 for the gadoxetic acid set and 0.980 and 0.975 for the combined set, respectively (P > .05). For detecting 105 biliary confluences with tumor involvement, the sensitivities with the combined set (97.1% [102 of 105] and 98.1% [103 of 105]) were higher than those with the gadoxetic acid set (91.4% [96 of 105] for both observers) (P = .029 and P = .016), although the specificities were similar with both image sets (P > .05). For the detection of liver invasion, the combined set (75.0% [15 of 20] for both observers) yielded better sensitivity than the gadoxetic acid set (50.0% [10 of 20] and 45.0% [nine of 20]) (P = .016 and P = .031). For evaluation of vascular invasion, the two image sets showed similar diagnostic performance.
CONCLUSION: In the preoperative evaluation of hilar cholangiocarcinoma, the addition of DW imaging to gadoxetic acid-enhanced MR imaging could improve sensitivity in the evaluation of tumor extent along the bile duct and liver invasion. RSNA, 2013

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24475800     DOI: 10.1148/radiol.13130009

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

Review 1.  Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Gino Puntel; Silvia Ortolani; Sara Cingarlini; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

2.  Peribiliary liver metastases MR findings.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Antonio Avallone; Maddalena Leongito; Francesco Izzo; Antonella Petrillo
Journal:  Med Oncol       Date:  2017-06-01       Impact factor: 3.064

3.  The Evaluation of Zoomed Echo-Planar Diffusion-Weighted Magnetic Resonance Imaging With Two-dimensional Spatial-Selective Radiofrequency Excitation Pulses in Patients With Hilar Cholangiocarcinoma.

Authors:  Jingjing Liu; Mengyue Huang; Yanan Ren; Man Xu; Yinhua Li; Jingliang Cheng; Jinxia Zhu
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

4.  Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Antonio Avallone; Raffaele Palaia; Gerardo Botti; Fabiana Tatangelo; Francesco Granata; Marco Cascella; Francesco Izzo; Antonella Petrillo
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

5.  Radiological assessment of secondary biliary tree lesions: an update.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venanzio Setola; Antonio Avallone; Raffaele Palaia; Roberto Grassi; Francesco Izzo; Antonella Petrillo
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

Review 6.  Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology.

Authors:  Dong Ho Lee; Bohyun Kim; Eun Sun Lee; Hyoung Jung Kim; Ji Hye Min; Jeong Min Lee; Moon Hyung Choi; Nieun Seo; Sang Hyun Choi; Seong Hyun Kim; Seung Soo Lee; Yang Shin Park; Yong Eun Chung
Journal:  Korean J Radiol       Date:  2020-08-28       Impact factor: 3.500

7.  Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer.

Authors:  Jeong Ah Hwang; Ji Hye Min; Seong Hyun Kim; Seo-Youn Choi; Ji Eun Lee; Ji Yoon Moon
Journal:  Korean J Radiol       Date:  2022-01-04       Impact factor: 3.500

Review 8.  [Current Status and Recent Update of Imaging Evaluation for Peri-Hilar Cholangiocarcinoma].

Authors:  Dong Ho Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-03-31

9.  Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.

Authors:  Xujian Huang; Jialin Yang; Jingdong Li; Yongfu Xiong
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.